Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor
- Registration Number
- NCT02262481
- Lead Sponsor
- Chulalongkorn University
- Brief Summary
The purpose of this study is to evaluate the effect of oral progesterone supplementation in preterm labor on the prevention of recurrent uterine contraction and prolonging pregnancy period, and its side effect.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 48
Inclusion Criteria
- Singleton pregnancy
- Preterm labor
- GA24-34wk
- Intact membranes
Read More
Exclusion Criteria
- Maternal/fetal condition requiring immediate delivery ex. Chorioamnionitis, fetal distress
- Placenta previa
- medical and obstetric complications
- allergy to dydrogesterone
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo placebo tocolytic + corticosteroids + Placebo prepare in capsule, 1 cap oral every 12 hours, starting form enrollment until gestational age 37 weeks Dydrogesterone dydrogesterone tocolytic + corticosteroids + Dydrogesterone 10 mg/tablet prepare in capsule, 1 cap oral every 12 hours, starting form enrollment until gestational age 37 weeks
- Primary Outcome Measures
Name Time Method The recurrence of uterine contraction within 48 hours after stop tocolytic 48 hours
- Secondary Outcome Measures
Name Time Method side effects 9 weeks Number of newborn with intraventricular hemorrhage 9 weeks Number of newborn with necrotizing enterocolitis 9 weeks Number of newborn with sepsis 9 weeks Time from preterm labor pain to delivery 9 weeks Number of newborn with respiratory distress syndrome 9 weeks Gestational age at delivery 9 weeks
Trial Locations
- Locations (1)
Faculty of Medicine, Chulalongkorn University
🇹ðŸ‡Bangkok, Thailand